Sign in:
Email
 Password  save:
  
 Company Reports 
 
   
My Recent Searches
  Help
 
   
 
 
 
  
   
Insider Information:   Elkins David V
Relationship:   Director
City:   Franklin Lakes
State:   NJ
   
Insider Summary:
  
   
Companies Owned :   4    
Direct Shares   196,756    

Indirect Shares

  216      
Direct Value   $8,815,924    

Indirect Value

  $9,688      
Total Shares   196,972      
Total Value   $8,825,612      


Bristol-Myers Squibb Co
 $8,744,315 Tapestry Inc
 $71,609 Bristol-Myers Squibb Co
 $8,744,315 Tapestry Inc
 $71,609
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :

    0   
    2    

     Stock price went up :

    0   
    1    
     Stock price went down :
    0   
    1    
   
     Gain/Loss Ratio :
   0.0   
   0.0   
     Percentage Gain/Loss :
     0.0%
 5.0%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Becton Dickinson & Co BDX Executive VP and CFO 2012-11-09 0 0    Premium*  
            Celgene Corp CELG 2019-11-20 0 2019-11-20 0    Premium*  
            Bristol-Myers Squibb Co BMY EVP, Chief Financial O... 2024-03-10 194,968 2024-03-10 216    Premium*  
            Tapestry Inc TPR Director 2024-02-29 1,788 2024-02-29 0    Premium*  
* Premium Members only  

Records found :    25         Free Registration Required For Full Results.    Limit: 25

Download
  Page 1 of 1
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

 
3m +/-  
Form
BMY Bristol-Myers Squibb Co EVP, Chief Financial Officer   •       –      –    2024-03-10 4 D $0.00 $0 D/D (19,448) 208,313 0 -
BMY Bristol-Myers Squibb Co EVP, Chief Financial Officer   •       –      –    2024-03-10 4 OE $0.00 $0 D/D 64,326 225,111 0 -
BMY Bristol-Myers Squibb Co EVP, Chief Financial Officer   •       –      –    2024-03-10 4 D $53.79 $996,298 D/D (18,522) 194,968 0 -
TPR Tapestry Inc Director   •       •      –    2024-02-29 4 A $47.53 $84,984 D/D 1,788 1,788 0 -
BMY Bristol-Myers Squibb Co EVP, Chief Financial Officer   •       –      –    2023-12-02 4 OE $0.00 $0 D/D 8,792 172,342 0 -
BMY Bristol-Myers Squibb Co EVP, Chief Financial Officer   •       –      –    2023-12-02 4 D $50.10 $186,873 D/D (3,730) 168,612 0 -
BMY Bristol-Myers Squibb Co EVP, Chief Financial Officer   •       –      –    2023-03-10 4 OE $0.00 $0 D/D 71,871 185,308 0 -
BMY Bristol-Myers Squibb Co EVP, Chief Financial Officer   •       –      –    2023-03-10 4 D $65.71 $2,715,860 D/D (41,331) 163,550 0 -
BMY Bristol-Myers Squibb Co EVP, Chief Financial Officer   •       –      –    2023-03-10 4 A $0.00 $0 D/D 8,930 191,187 0 -
BMY Bristol-Myers Squibb Co EVP, Chief Financial Officer   •       –      –    2022-12-02 4 D $81.13 $364,923 D/D (4,498) 124,080 0 -
BMY Bristol-Myers Squibb Co EVP, Chief Financial Officer   •       –      –    2022-12-02 4 OE $0.00 $0 D/D 8,792 128,578 0 -
BMY Bristol-Myers Squibb Co EVP, Chief Financial Officer   •       –      –    2022-09-13 4 S $71.29 $9,551,167 D/D (133,951) 119,786 0 %
BMY Bristol-Myers Squibb Co EVP, Chief Financial Officer   •       –      –    2022-09-13 4 OE $48.49 $5,977,702 D/D 123,277 223,737 0 -
BMY Bristol-Myers Squibb Co EVP, Chief Financial Officer   •       –      –    2022-03-10 4 OE $0.00 $0 D/D 16,067 134,133 0 -
BMY Bristol-Myers Squibb Co EVP, Chief Financial Officer   •       –      –    2022-03-10 4 A $0.00 $0 D/D 1,962 135,035 0 -
BMY Bristol-Myers Squibb Co EVP, Chief Financial Officer   •       –      –    2022-03-10 4 D $68.42 $630,969 D/D (9,222) 130,460 0 -
BMY Bristol-Myers Squibb Co EVP, Chief Financial Officer   •       –      –    2022-03-01 4 D $68.63 $712,448 D/D (10,381) 121,653 0 -
BMY Bristol-Myers Squibb Co EVP, Chief Financial Officer   •       –      –    2022-03-01 4 OE $0.00 $0 D/D 24,577 132,034 0 -
BMY Bristol-Myers Squibb Co EVP, Chief Financial Officer   •       –      –    2021-12-31 4 OE $0.00 $0 D/D 47,401 131,703 0 -
BMY Bristol-Myers Squibb Co EVP, Chief Financial Officer   •       –      –    2021-12-31 4 D $62.35 $1,511,738 D/D (24,246) 107,457 0 -
BMY Bristol-Myers Squibb Co EVP, Chief Financial Officer   •       –      –    2021-12-02 4 D $55.41 $249,234 D/D (4,498) 84,302 0 -
BMY Bristol-Myers Squibb Co EVP, Chief Financial Officer   •       –      –    2021-12-02 4 OE $0.00 $0 D/D 8,792 88,800 0 -
BMY Bristol-Myers Squibb Co EVP, Chief Financial Officer   •       –      –    2021-08-12 4 S $66.88 $6,674,497 D/D (99,691) 80,008 0 %
BMY Bristol-Myers Squibb Co EVP, Chief Financial Officer   •       –      –    2021-08-12 4 OE $48.49 $3,394,300 D/D 70,000 139,699 0 -
BMY Bristol-Myers Squibb Co EVP, Chief Financial Officer   •       –      –    2021-08-01 4 D $67.87 $1,610,962 D/D (23,736) 109,699 0 -

  25  Records found
  1     
  Page 1 of 1  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed